In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing
COVID-19 caused by SARS-CoV-2 is a global health issue. It is yet a severe risk factor to the
patients, who are also suffering from one or more chronic diseases including different lung …
patients, who are also suffering from one or more chronic diseases including different lung …
Discovering common pathogenetic processes between COVID-19 and tuberculosis by bioinformatics and system biology approach
T Huang, J He, X Zhou, H Pan, F He, A Du… - Frontiers in Cellular …, 2023 - frontiersin.org
Introduction The coronavirus disease 2019 (COVID-19) pandemic, stemming from the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has persistently …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has persistently …
Bioinformatics and system biology approaches to determine the connection of SARS-CoV-2 infection and intrahepatic cholangiocarcinoma
X Zhou, T Huang, H Pan, A Du, T Wu, J Lan, Y Song… - Plos one, 2024 - journals.plos.org
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal
agent of coronavirus disease 2019 (COVID-19), has infected millions of individuals …
agent of coronavirus disease 2019 (COVID-19), has infected millions of individuals …